These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21556051)

  • 1. Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.
    Chen Z; Zhang C; Wu D; Chen H; Rorick A; Zhang X; Wang Q
    EMBO J; 2011 May; 30(12):2405-19. PubMed ID: 21556051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.
    Liu G; Sprenger C; Wu PJ; Sun S; Uo T; Haugk K; Epilepsia KS; Plymate S
    Oncotarget; 2015 Jan; 6(1):288-304. PubMed ID: 25481872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.
    Wang H; Zhang C; Rorick A; Wu D; Chiu M; Thomas-Ahner J; Chen Z; Chen H; Clinton SK; Chan KK; Wang Q
    Cancer Res; 2011 Jul; 71(14):4866-76. PubMed ID: 21593191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.
    Rasool RU; Natesan R; Deng Q; Aras S; Lal P; Sander Effron S; Mitchell-Velasquez E; Posimo JM; Carskadon S; Baca SC; Pomerantz MM; Siddiqui J; Schwartz LE; Lee DJ; Palanisamy N; Narla G; Den RB; Freedman ML; Brady DC; Asangani IA
    Cancer Discov; 2019 Nov; 9(11):1538-1555. PubMed ID: 31466944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.
    Jin F; Irshad S; Yu W; Belakavadi M; Chekmareva M; Ittmann MM; Abate-Shen C; Fondell JD
    Mol Cancer Res; 2013 Jul; 11(7):736-47. PubMed ID: 23538858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
    Hu R; Lu C; Mostaghel EA; Yegnasubramanian S; Gurel M; Tannahill C; Edwards J; Isaacs WB; Nelson PS; Bluemn E; Plymate SR; Luo J
    Cancer Res; 2012 Jul; 72(14):3457-62. PubMed ID: 22710436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.
    Decker KF; Zheng D; He Y; Bowman T; Edwards JR; Jia L
    Nucleic Acids Res; 2012 Nov; 40(21):10765-79. PubMed ID: 23019221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.
    Hsieh CL; Fei T; Chen Y; Li T; Gao Y; Wang X; Sun T; Sweeney CJ; Lee GS; Chen S; Balk SP; Liu XS; Brown M; Kantoff PW
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7319-24. PubMed ID: 24778216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1.
    Russo JW; Nouri M; Balk SP
    Cancer Discov; 2019 Nov; 9(11):1490-1492. PubMed ID: 31676563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling.
    Hall DD; Spitler KM; Grueter CE
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H314-H325. PubMed ID: 30461303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.
    Jin F; Claessens F; Fondell JD
    J Biol Chem; 2012 Jan; 287(2):858-70. PubMed ID: 22102282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.
    Yang L; Lin C; Jin C; Yang JC; Tanasa B; Li W; Merkurjev D; Ohgi KA; Meng D; Zhang J; Evans CP; Rosenfeld MG
    Nature; 2013 Aug; 500(7464):598-602. PubMed ID: 23945587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
    Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
    Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.
    Zhao Y; Wang L; Ren S; Wang L; Blackburn PR; McNulty MS; Gao X; Qiao M; Vessella RL; Kohli M; Zhang J; Karnes RJ; Tindall DJ; Kim Y; MacLeod R; Ekker SC; Kang T; Sun Y; Huang H
    Cell Rep; 2016 Apr; 15(3):599-610. PubMed ID: 27068475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
    Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
    Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
    Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
    Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.
    Sunkel B; Wu D; Chen Z; Wang CM; Liu X; Ye Z; Horning AM; Liu J; Mahalingam D; Lopez-Nicora H; Lin CL; Goodfellow PJ; Clinton SK; Jin VX; Chen CL; Huang TH; Wang Q
    Nucleic Acids Res; 2016 May; 44(9):4105-22. PubMed ID: 26743006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.